Skip to main content
Clinical Trials/ACTRN12622000766718
ACTRN12622000766718
Recruiting
未知

A cluster randomised controlled trial evaluating the efficacy of a practice nurse-coordinated intervention targeting treatable traits in moderate-severe COPD in primary care, compared with usual care, and its effect on health-related quality of life (HRQoL) and hospitalisations/emergency department (ED) visits

Monash University0 sites400 target enrollmentMay 30, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Sponsor
Monash University
Enrollment
400
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 30, 2022
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Community dwelling adults aged 18 years and above with a history of mild\-severe COPD and with a history of at least one exacerbation in the previous 24 months (based on self\-reported COPD\-related hospitalisation or use of short course oral steroids and/or antibiotics) will be eligible.

Exclusion Criteria

  • Those unable to provide informed consent e.g. cognitive impairment, unable to communicate in English, with difficulty following the intervention, with a terminal illness (anticipated survival \<12 months), symptoms suggesting unstable heart disease, or contraindications to spirometry as per standard guidelines will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials